{"transactions":[{"id":2013815,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116854,"kind":"person","name":"Brake Rachael Louise","position":1,"cik":"0001898023","reported_name":"Brake Rachael Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-15T12:56:03.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":1400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 13 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":1400000,"derivative":{"exercise_price":0.142,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":1400000},"source":{"system":"sec-edgar","filing":"0001209191-23-009635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898023/000120919123009635/doc4.xml","form_type":"4"}},{"id":2417081,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116854,"kind":"person","name":"Brake Rachael Louise","position":1,"cik":"0001898023","reported_name":"Brake Rachael Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T17:49:38.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":570800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023."}],"balance_after":570800,"derivative":{"exercise_price":0.47,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":570800},"source":{"system":"sec-edgar","filing":"0001209191-22-006511","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898023/000120919122006511/doc4.xml","form_type":"4"}},{"id":2480982,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":116854,"kind":"person","name":"Brake Rachael Louise","position":1,"cik":"0001898023","reported_name":"Brake Rachael Louise","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option(right to buy)","published_at":"2021-12-08T16:04:38.000Z","date":"2021-12-06","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on December 6, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on January 6, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on December 6, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on January 6, 2023."}],"balance_after":500000,"derivative":{"exercise_price":0.7474,"expiration_date":"2031-12-06","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-21-068508","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1898023/000120919121068508/doc4.xml","form_type":"4"}}]}